Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction, a sub-study of DAPA-VO2.

Back

HFA Premium Access

Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction, a sub-study of DAPA-VO2.

Session: Chronic heart Failure - biomarkers 2

Topic: Biomarkers

Speaker: Miss M. Amiguet Comins (Castellon de la Plana, ES)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Miss Martina Amiguet Comins

General University Hospital of Castellon, Castellon de la Plana (Spain)

0 follower

7 more presentations in this session

Altered myokine profile and glycemic control in type 2 diabetes mellitus patients with heart failure

Speaker: Professor A. Berezin (Salzburg, AT)

Access

Abstract

Slides

Endothelial dysfunction represented by the endothelial activation and stress index (EASIX) is associated with lower overall survival in chronic heart failure patients

Speaker: Mr B. Estler (Heidelberg, DE)

Access

Abstract

Slides

NT-pro-BNP as only biomarker for the monitoring of cardiac amyloidosis patients

Speaker: Miss J. Krief (Montpellier, FR)

Access

Abstract

Slides

Secretoneurin is produced and released from the myocardium of patients with Takotsubo syndrome

Speaker: Professor H. Rosjo (Nordbyhagen, NO)

Access

Abstract

Slides

Vascular endothelial growth factor C as a potential biomarker of peripheral tissue congestion in acute heart failure.

Speaker: Mr G. Iwanek (Wroclaw, PL)

Access

Abstract

Slides

Access the full session

Chronic heart Failure - biomarkers 2

Speakers: Miss M. Amiguet Comins, Professor A. Berezin, Mr B. Estler, Miss J. Krief, Professor H. Rosjo...

Access

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources